Gossamer Bio Stock Filter Stocks by Fundamentals
| GOSS Stock | USD 0.81 0.01 1.22% |
Gossamer Bio fundamentals help investors to digest information that contributes to Gossamer Bio's financial success or failures. It also enables traders to predict the movement of Gossamer Stock. The fundamental analysis module provides a way to measure Gossamer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gossamer Bio stock.
Gossamer | Shares Owned by Institutions |
Gossamer Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Gossamer Bio from analyzing Gossamer Bio's financial statements. These drivers represent accounts that assess Gossamer Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Gossamer Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 855.6M | 662.5M | 846.5M | 183.5M | 139.3M | 132.3M | |
| Enterprise Value | 760.0M | 360.2M | 848.3M | 297.3M | 319.6M | 613.3M |
Gossamer Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Gossamer Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Gossamer Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Gossamer Bio's value.| Shares | Farallon Capital Management, L.l.c. | 2023-12-31 | 6.1 M | Silverarc Capital Management, Llc | 2023-12-31 | 6.1 M | Samsara Biocapital, Llc | 2023-12-31 | 6.1 M | Palo Alto Investors, Llc | 2023-12-31 | 6 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 5.6 M | Goldman Sachs Group Inc | 2023-12-31 | 5.5 M | Madison Avenue Partners, Lp | 2023-12-31 | 5.1 M | Hillhouse Capital Advisors, Ltd. | 2023-12-31 | 5 M | Millennium Management Llc | 2023-12-31 | 4.2 M | Nea Management Company, Llc | 2023-12-31 | 15.8 M | Fmr Inc | 2023-12-31 | 12.3 M |
Gossamer Fundamentals
| Return On Equity | -4.8 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | 97.86 M | ||||
| Shares Outstanding | 225.58 M | ||||
| Shares Owned By Insiders | 2.24 % | ||||
| Shares Owned By Institutions | 93.16 % | ||||
| Number Of Shares Shorted | 10.76 M | ||||
| Price To Earning | (4.61) X | ||||
| Price To Book | 3.22 X | ||||
| EBITDA | (169.37 M) | ||||
| Net Income | (179.82 M) | ||||
| Cash And Equivalents | 304.38 M | ||||
| Cash Per Share | 3.29 X | ||||
| Total Debt | 212.46 M | ||||
| Debt To Equity | 3.86 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 0.28 X | ||||
| Cash Flow From Operations | (159.16 M) | ||||
| Short Ratio | 7.28 X | ||||
| Earnings Per Share | (1.18) X | ||||
| Price To Earnings To Growth | (0.63) X | ||||
| Target Price | 5.72 | ||||
| Number Of Employees | 135 | ||||
| Beta | 1.74 | ||||
| Market Capitalization | 181.82 M | ||||
| Total Asset | 311.92 M | ||||
| Retained Earnings | (1.21 B) | ||||
| Working Capital | 254.92 M | ||||
| Current Asset | 441.63 M | ||||
| Current Liabilities | 39.84 M | ||||
| Net Asset | 311.92 M |
About Gossamer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gossamer Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gossamer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gossamer Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Gossamer Bio Piotroski F Score and Gossamer Bio Altman Z Score analysis. For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Gossamer Stock analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Gossamer Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gossamer Bio. If investors know Gossamer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gossamer Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Return On Assets (0.37) | Return On Equity (4.80) |
The market value of Gossamer Bio is measured differently than its book value, which is the value of Gossamer that is recorded on the company's balance sheet. Investors also form their own opinion of Gossamer Bio's value that differs from its market value or its book value, called intrinsic value, which is Gossamer Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gossamer Bio's market value can be influenced by many factors that don't directly affect Gossamer Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gossamer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gossamer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gossamer Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.